Skip to content
naulon

Not checkedNot checked for notices yet.

Idebenone increases mitochondrial complex I activity in fibroblasts from LHON patients while producing contradictory effects on respiration

Angebault Claire, Gueguen Naïg, Desquiret-Dumas Valérie and 11 more

BMC Research Notes · 2011

doi:10.1186/1756-0500-4-557 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

<p>Abstract</p> <p>Background</p> <p>Leber's hereditary optic neuropathy (LHON) is caused by mutations in the complex I subunits of the respiratory chain. Although patients have been treated with idebenone since 1992, the efficacy of the drug is still a matter of debate.</p> <p>Methods</p> <p>We evaluated the effect of idebenone in fibroblasts from LHON patients using enzymatic and polarographic measurements.</p> <p>Results</p> <p>Complex I activity was 42% greater in treated fibroblasts compared to controls (<it>p </it>= 0.002). Despite this complex I activity improvement, the effects on mitochondrial respiration were contradictory, leading to impairment in some cases and stimulation in others.</p> <p>Conclusion</p> <p>These results indicate that idebenone is able to compensate the complex I deficiency in LHON patient cells with variable effects on respiration, indicating that the patients might not be equally likely to benefit from the treatment.</p>

Abstract licence: CC BY-NC-ND

Cited by papers we hold1

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.